Prevalence and status of Lipoprotein (a) among Lebanese school children.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 11 2020
Historique:
received: 20 08 2020
accepted: 13 11 2020
entrez: 27 11 2020
pubmed: 28 11 2020
medline: 16 3 2021
Statut: epublish

Résumé

Lipoprotein a (Lp(a) is an independent risk factor for atherosclerotic cardiovascular disease. The prevalence of high Lipoprotein (a) (Lp(a)) in the Lebanese pediatric population is unknown. Our study aims to assess this prevalence and to study the relationship of Lp(a) with the lipid profile, age, body mass index (BMI) and socio-economic status (SES) in Lebanese schoolchildren. A total of 961 children aged 8-18 years (497 boys and 464 girls) were recruited from ten private and public schools in 2013-2014 using a stratified random sample. Schools were selected from the Greater Beirut and Mount Lebanon areas, and were categorized into three subgroups according to the schools' SES status (high, medium, low). Lp(a) was assayed in 2018 on samples previously frozen at - 80 °C. Abnormal Lp(a) levels (≥ 75 nmol/L) were observed in 14.4% of the overall sample (13.5% for boys,15.3% of girls p = 0.56). The median of Lp(a) was 20(10-50) in the whole sample with no significant gender difference. No significant relationship was found between Lp(a) and age. However, Lp(a) was significantly correlated with BMI in whole sample, as well as in boys and girls (p = 0.02, p = 0.03, p = 0.03, respectively). A significant correlation was found between Lp(a) and non-HDL-C in the whole sample as well as in boys and girls (respectively p < 0.001,p = 0.024 and p = 0.03), but not with triglycerides and HDL-C. In a multivariate linear regression analysis, Lp(a) was only independently associated with BMI and non-HDL-C in boys and girls. Lp(a) was independently associated with BMI and non-HDL-C while no significant relationship was observed with age and sex confirming the strong genetic determination of Lp(a).

Identifiants

pubmed: 33244019
doi: 10.1038/s41598-020-77689-5
pii: 10.1038/s41598-020-77689-5
pmc: PMC7692560
doi:

Substances chimiques

Cholesterol, HDL 0
Lipids 0
Lipoprotein(a) 0
Triglycerides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20620

Références

Cardiol Clin. 2018 May;36(2):287-298
pubmed: 29609758
Curr Atheroscler Rep. 2013 Oct;15(10):360
pubmed: 23990263
J Endocrinol Invest. 2003 May;26(5):414-9
pubmed: 12906368
Mayo Clin Proc. 2013 Nov;88(11):1294-311
pubmed: 24182706
Eur Heart J. 2010 Dec;31(23):2844-53
pubmed: 20965889
J Am Coll Cardiol. 2017 Feb 14;69(6):692-711
pubmed: 28183512
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
Eur Heart J. 2018 Jul 14;39(27):2589-2596
pubmed: 29931232
Int J Obes (Lond). 2009 Oct;33(10):1136-42
pubmed: 19636317
JAMA. 2009 Jul 22;302(4):412-23
pubmed: 19622820
Eur J Clin Nutr. 2020 Aug;74(8):1157-1163
pubmed: 32127687
An Pediatr (Barc). 2006 Mar;64(3):235-8
pubmed: 16527089
Atherosclerosis. 2020 Feb;294:46-61
pubmed: 31928713
J Clin Invest. 1992 Jul;90(1):52-60
pubmed: 1386087
Pediatr Cardiol. 2018 Dec;39(8):1540-1546
pubmed: 29948030
J Clin Lipidol. 2016 Mar-Apr;10(2):378-85
pubmed: 27055969
J Lipid Res. 2016 May;57(5):745-57
pubmed: 26647358
Clin Biochem Rev. 2018 Aug;39(3):65-76
pubmed: 30828113
J Lipid Res. 2016 Nov;57(11):1953-1975
pubmed: 27677946
Haematologica. 2013 May;98(5):802-7
pubmed: 23349301
Lipids Health Dis. 2004 Dec 16;3:29
pubmed: 15601478
Atherosclerosis. 2003 Apr;167(2):275-86
pubmed: 12818410
J Lipid Res. 1991 Sep;32(9):1513-9
pubmed: 1836489
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Cardiovasc Diabetol. 2012 Jan 27;11:10
pubmed: 22283971
Indian J Clin Biochem. 2012 Jul;27(3):231-8
pubmed: 26405380
Stroke. 2007 Jun;38(6):1959-66
pubmed: 17478739
Prog Lipid Res. 2017 Oct;68:57-82
pubmed: 28888913
J Clin Lipidol. 2019 May - Jun;13(3):374-392
pubmed: 31147269
Thromb Res. 2006;117(6):631-7
pubmed: 15985286
Ann Biol Clin (Paris). 1999 Nov-Dec;57(6):697-703
pubmed: 10572218
J Lipid Res. 2016 Apr;57(4):526-37
pubmed: 26637278
Eur J Epidemiol. 2000 Jan;16(1):5-12
pubmed: 10780336
JAMA. 2009 Jun 10;301(22):2331-9
pubmed: 19509380

Auteurs

Marie-Hélène Gannagé-Yared (MH)

Department of Endocrinology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon. mariehelene.yared@usj.edu.lb.
Division of Endocrinology, Hotel-Dieu de France Hospital, Beirut, Lebanon. mariehelene.yared@usj.edu.lb.

Christina Lahoud (C)

Department of Endocrinology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Nada Younes (N)

Department of Endocrinology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Rima Chedid (R)

Department of Endocrinology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Ghassan Sleilaty (G)

Department of Biostatistics and Clinical Research Center, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH